Scientific

MK5 Microarray Data


Affected Genes - Ontology Breakdown - Gene Enrichment - Proteome Analysis

These are the micro-array results of a differential gene expression microarray experiments and the subsequent analysis steps performed on them. The up/down- regulation ratio was obtained by measuring WT cells against MK5 activated cells. See material and methods for technical information as well as the data usage policy.

Proteome Analysis

Below the proteome analysis is presented. The analysis methods are presented in the paper Propagating Differential Gene Expression in Protein Interaction Networks. If you are interested in the most reliable results choose the

  • value_type as 'ranked' since this provides a very robust analysis method.
  • intercation map as 'high confidence'
  • network_comparison type as 'Divided' since this leads to a natural grouping of similar proteins
  • filtered as 'true' since this will only use the microarray measurements that have a sufficiently large confidence level.

  • Navigation/Query Panel:
    Click on the attribute name to hide/unhide it. The green arrows can be used to shift columns left/right. Exact word match is written as =..., regular expressions can be matched with ~.... To select all values larger or equal than use >.... This would be <... for values smaller or equal than. To select all values within a specific range use [...,...].
    Rank Gene Hugo description Value Type Network Comparison Type Interaction Map Filtered red green network_comparison
    Results: HTML CSV LaTeX Showing element 500 to 549 of 3228 in total
    Value Type: Ranked
    Network Comparison Type: Divided
    Interaction Map: High confidence
    Filtered: 1
    \def\wcA{0.14285714285714\textwidth} \def\wcB{0.14285714285714\textwidth} \def\wcC{0.14285714285714\textwidth} \def\wcD{0.14285714285714\textwidth} \def\wcE{0.14285714285714\textwidth} \def\wcF{0.14285714285714\textwidth} \begin{longtable}{|c|c|c|c|c|c|} \hline \parbox{\wcA}{\vspace{3pt}\noindent Rank\vspace{3pt}}&\parbox{\wcB}{\vspace{3pt}\noindent Hugo\vspace{3pt}}&\parbox{\wcC}{\vspace{3pt}\noindent description\vspace{3pt}}&\parbox{\wcD}{\vspace{3pt}\noindent red\vspace{3pt}}&\parbox{\wcE}{\vspace{3pt}\noindent green\vspace{3pt}}&\parbox{\wcF}{\vspace{3pt}\noindent network\_comparison\vspace{3pt}}\\ \hline \hline \parbox{\wcA}{\vspace{3pt}\noindent 500\vspace{3pt}}&\parbox{\wcB}{\vspace{3pt}\noindent ING2\vspace{3pt}}&\parbox{\wcC}{\vspace{3pt}\noindent inhibitor of growth family, member 1-like; inhibitor of growth 1-like. [source:refseq;acc:nm\_001564]\vspace{3pt}}&\parbox{\wcD}{\vspace{3pt}\noindent 224.662\vspace{3pt}}&\parbox{\wcE}{\vspace{3pt}\noindent 240.673\vspace{3pt}}&\parbox{\wcF}{\vspace{3pt}\noindent 1.07127\vspace{3pt}}\\\hline \parbox{\wcA}{\vspace{3pt}\noindent 501\vspace{3pt}}&\parbox{\wcB}{\vspace{3pt}\noindent CYC1\vspace{3pt}}&\parbox{\wcC}{\vspace{3pt}\noindent cytochrome c1, heme protein, mitochondrial precursor (cytochrome c-1). [source:swissprot;acc:p08574]\vspace{3pt}}&\multirow{4}{*}{\parbox{\wcD}{\vspace{3pt}\noindent 238.704\vspace{3pt}}}&\multirow{4}{*}{\parbox{\wcE}{\vspace{3pt}\noindent 255.68\vspace{3pt}}}&\multirow{4}{*}{\parbox{\wcF}{\vspace{3pt}\noindent 1.07112\vspace{3pt}}}\\\cline{1-3} \parbox{\wcA}{\vspace{3pt}\noindent 502\vspace{3pt}}&\parbox{\wcB}{\vspace{3pt}\noindent ARHGAP26\vspace{3pt}}&\parbox{\wcC}{\vspace{3pt}\noindent oligophrenin-1 like protein (gtpase regulator associated with focal adhesion kinase). [source:swissprot;acc:q9una1]\vspace{3pt}}&&&\\\cline{1-3} \parbox{\wcA}{\vspace{3pt}\noindent 503\vspace{3pt}}&\parbox{\wcB}{\vspace{3pt}\noindent RGN\vspace{3pt}}&\parbox{\wcC}{\vspace{3pt}\noindent senescence marker protein-30 (smp-30) (regucalcin) (rc). [source:swissprot;acc:q15493]\vspace{3pt}}&&&\\\cline{1-3} \parbox{\wcA}{\vspace{3pt}\noindent 504\vspace{3pt}}&\parbox{\wcB}{\vspace{3pt}\noindent OPHN1\vspace{3pt}}&\parbox{\wcC}{\vspace{3pt}\noindent oligophrenin 1. [source:swissprot;acc:o60890]\vspace{3pt}}&&&\\\hline \parbox{\wcA}{\vspace{3pt}\noindent 505\vspace{3pt}}&\parbox{\wcB}{\vspace{3pt}\noindent NOC3L\vspace{3pt}}&\parbox{\wcC}{\vspace{3pt}\noindent ad24 protein. [source:refseq;acc:nm\_022451]\vspace{3pt}}&\parbox{\wcD}{\vspace{3pt}\noindent 251.334\vspace{3pt}}&\parbox{\wcE}{\vspace{3pt}\noindent 234.672\vspace{3pt}}&\multirow{2}{*}{\parbox{\wcF}{\vspace{3pt}\noindent 1.071\vspace{3pt}}}\\\cline{1-5} \parbox{\wcA}{\vspace{3pt}\noindent 506\vspace{3pt}}&\parbox{\wcB}{\vspace{3pt}\noindent ING1\vspace{3pt}}&\parbox{\wcC}{\vspace{3pt}\noindent inhibitor of growth family, member 1; inhibitor of growth 1. [source:refseq;acc:nm\_005537]\vspace{3pt}}&\parbox{\wcD}{\vspace{3pt}\noindent 224.535\vspace{3pt}}&\parbox{\wcE}{\vspace{3pt}\noindent 240.476\vspace{3pt}}&\\\hline \parbox{\wcA}{\vspace{3pt}\noindent 507\vspace{3pt}}&\parbox{\wcB}{\vspace{3pt}\noindent WDR12\vspace{3pt}}&\parbox{\wcC}{\vspace{3pt}\noindent wd-repeat protein 12 (ytm1 homolog). [source:swissprot;acc:q9gzl7]\vspace{3pt}}&\parbox{\wcD}{\vspace{3pt}\noindent 251.299\vspace{3pt}}&\parbox{\wcE}{\vspace{3pt}\noindent 234.729\vspace{3pt}}&\parbox{\wcF}{\vspace{3pt}\noindent 1.07059\vspace{3pt}}\\\hline \parbox{\wcA}{\vspace{3pt}\noindent 508\vspace{3pt}}&\parbox{\wcB}{\vspace{3pt}\noindent CPA3\vspace{3pt}}&\parbox{\wcC}{\vspace{3pt}\noindent mast cell carboxypeptidase a precursor (ec 3.4.17.1) (mc-cpa) (carboxypeptidase a3). [source:swissprot;acc:p15088]\vspace{3pt}}&\multirow{2}{*}{\parbox{\wcD}{\vspace{3pt}\noindent 177.698\vspace{3pt}}}&\parbox{\wcE}{\vspace{3pt}\noindent 190.24\vspace{3pt}}&\parbox{\wcF}{\vspace{3pt}\noindent 1.07058\vspace{3pt}}\\\cline{1-3}\cline{5-6} \parbox{\wcA}{\vspace{3pt}\noindent 509\vspace{3pt}}&\parbox{\wcB}{\vspace{3pt}\noindent CPA6\vspace{3pt}}&\parbox{\wcC}{\vspace{3pt}\noindent carboxypeptidase b precursor. [source:refseq;acc:nm\_020361]\vspace{3pt}}&&\parbox{\wcE}{\vspace{3pt}\noindent 190.239\vspace{3pt}}&\multirow{2}{*}{\parbox{\wcF}{\vspace{3pt}\noindent 1.07057\vspace{3pt}}}\\\cline{1-5} \parbox{\wcA}{\vspace{3pt}\noindent 510\vspace{3pt}}&\parbox{\wcB}{\vspace{3pt}\noindent CPB2\vspace{3pt}}&\parbox{\wcC}{\vspace{3pt}\noindent plasma carboxypeptidase b2 isoform a preproprotein; carboxypeptidase u; thrombin-activatable fibrinolysis inhibitor; carboxypeptidase b-like protein; thrombin-activable fibrinolysis inhibitor. [source:refseq;acc:nm\_001872]\vspace{3pt}}&\parbox{\wcD}{\vspace{3pt}\noindent 177.699\vspace{3pt}}&\parbox{\wcE}{\vspace{3pt}\noindent 190.24\vspace{3pt}}&\\\hline \parbox{\wcA}{\vspace{3pt}\noindent 511\vspace{3pt}}&\parbox{\wcB}{\vspace{3pt}\noindent NOL1\vspace{3pt}}&\parbox{\wcC}{\vspace{3pt}\noindent proliferating-cell nucleolar antigen p120 (proliferation-associated nucleolar protein p120). [source:swissprot;acc:p46087]\vspace{3pt}}&\parbox{\wcD}{\vspace{3pt}\noindent 250.053\vspace{3pt}}&\parbox{\wcE}{\vspace{3pt}\noindent 233.725\vspace{3pt}}&\parbox{\wcF}{\vspace{3pt}\noindent 1.06986\vspace{3pt}}\\\hline \parbox{\wcA}{\vspace{3pt}\noindent 512\vspace{3pt}}&\parbox{\wcB}{\vspace{3pt}\noindent BOP1\vspace{3pt}}&\parbox{\wcC}{\vspace{3pt}\noindent block of proliferation 1. [source:swissprot;acc:q14137]\vspace{3pt}}&\parbox{\wcD}{\vspace{3pt}\noindent 250.794\vspace{3pt}}&\parbox{\wcE}{\vspace{3pt}\noindent 234.433\vspace{3pt}}&\parbox{\wcF}{\vspace{3pt}\noindent 1.06979\vspace{3pt}}\\\hline \parbox{\wcA}{\vspace{3pt}\noindent 513\vspace{3pt}}&\parbox{\wcB}{\vspace{3pt}\noindent DVL1\vspace{3pt}}&\parbox{\wcC}{\vspace{3pt}\noindent segment polarity protein dishevelled homolog dvl-1 (dishevelled-1) (dsh homolog 1). [source:swissprot;acc:o14640]\vspace{3pt}}&\parbox{\wcD}{\vspace{3pt}\noindent 218.596\vspace{3pt}}&\parbox{\wcE}{\vspace{3pt}\noindent 204.344\vspace{3pt}}&\parbox{\wcF}{\vspace{3pt}\noindent 1.06975\vspace{3pt}}\\\hline \parbox{\wcA}{\vspace{3pt}\noindent 514\vspace{3pt}}&\parbox{\wcB}{\vspace{3pt}\noindent DVL2\vspace{3pt}}&\parbox{\wcC}{\vspace{3pt}\noindent segment polarity protein dishevelled homolog dvl-2 (dishevelled-2) (dsh homolog 2). [source:swissprot;acc:o14641]\vspace{3pt}}&\parbox{\wcD}{\vspace{3pt}\noindent 218.613\vspace{3pt}}&\parbox{\wcE}{\vspace{3pt}\noindent 204.382\vspace{3pt}}&\parbox{\wcF}{\vspace{3pt}\noindent 1.06963\vspace{3pt}}\\\hline \parbox{\wcA}{\vspace{3pt}\noindent 515\vspace{3pt}}&\parbox{\wcB}{\vspace{3pt}\noindent PES1\vspace{3pt}}&\parbox{\wcC}{\vspace{3pt}\noindent pescadillo homolog 1. [source:swissprot;acc:o00541]\vspace{3pt}}&\parbox{\wcD}{\vspace{3pt}\noindent 251.297\vspace{3pt}}&\parbox{\wcE}{\vspace{3pt}\noindent 234.941\vspace{3pt}}&\parbox{\wcF}{\vspace{3pt}\noindent 1.06962\vspace{3pt}}\\\hline \parbox{\wcA}{\vspace{3pt}\noindent 516\vspace{3pt}}&\parbox{\wcB}{\vspace{3pt}\noindent LSM8\vspace{3pt}}&\parbox{\wcC}{\vspace{3pt}\noindent u6 snrna-associated sm-like protein lsm8. [source:swissprot;acc:o95777]\vspace{3pt}}&\parbox{\wcD}{\vspace{3pt}\noindent 228.255\vspace{3pt}}&\parbox{\wcE}{\vspace{3pt}\noindent 213.422\vspace{3pt}}&\parbox{\wcF}{\vspace{3pt}\noindent 1.0695\vspace{3pt}}\\\hline \parbox{\wcA}{\vspace{3pt}\noindent 517\vspace{3pt}}&\parbox{\wcB}{\vspace{3pt}\noindent MTX2\vspace{3pt}}&\parbox{\wcC}{\vspace{3pt}\noindent metaxin 2. [source:swissprot;acc:o75431]\vspace{3pt}}&\parbox{\wcD}{\vspace{3pt}\noindent 219.537\vspace{3pt}}&\parbox{\wcE}{\vspace{3pt}\noindent 234.793\vspace{3pt}}&\parbox{\wcF}{\vspace{3pt}\noindent 1.06949\vspace{3pt}}\\\hline \parbox{\wcA}{\vspace{3pt}\noindent 518\vspace{3pt}}&\parbox{\wcB}{\vspace{3pt}\noindent GNL3\vspace{3pt}}&\parbox{\wcC}{\vspace{3pt}\noindent nucleostemin; putative nucleotide binding protein, estradiol-induced. [source:refseq;acc:nm\_014366]\vspace{3pt}}&\parbox{\wcD}{\vspace{3pt}\noindent 250.858\vspace{3pt}}&\parbox{\wcE}{\vspace{3pt}\noindent 234.563\vspace{3pt}}&\parbox{\wcF}{\vspace{3pt}\noindent 1.06947\vspace{3pt}}\\\hline \parbox{\wcA}{\vspace{3pt}\noindent 519\vspace{3pt}}&\parbox{\wcB}{\vspace{3pt}\noindent DVL3\vspace{3pt}}&\parbox{\wcC}{\vspace{3pt}\noindent segment polarity protein dishevelled homolog dvl-3 (dishevelled-3) (dsh homolog 3). [source:swissprot;acc:q92997]\vspace{3pt}}&\parbox{\wcD}{\vspace{3pt}\noindent 218.702\vspace{3pt}}&\parbox{\wcE}{\vspace{3pt}\noindent 204.582\vspace{3pt}}&\parbox{\wcF}{\vspace{3pt}\noindent 1.06902\vspace{3pt}}\\\hline \parbox{\wcA}{\vspace{3pt}\noindent 520\vspace{3pt}}&\parbox{\wcB}{\vspace{3pt}\noindent SLC35D2\vspace{3pt}}&\parbox{\wcC}{\vspace{3pt}\noindent sqv-7-like protein (fragment). [source:sptrembl;acc:o95454]\vspace{3pt}}&\parbox{\wcD}{\vspace{3pt}\noindent 214.754\vspace{3pt}}&\parbox{\wcE}{\vspace{3pt}\noindent 229.565\vspace{3pt}}&\parbox{\wcF}{\vspace{3pt}\noindent 1.06897\vspace{3pt}}\\\hline \parbox{\wcA}{\vspace{3pt}\noindent 521\vspace{3pt}}&\parbox{\wcB}{\vspace{3pt}\noindent EXOSC4\vspace{3pt}}&\parbox{\wcC}{\vspace{3pt}\noindent exosome complex exonuclease rrp41 (ec 3.1.13.-) (ribosomal rna processing protein 41) (p12a). [source:swissprot;acc:q9npd3]\vspace{3pt}}&\parbox{\wcD}{\vspace{3pt}\noindent 215.237\vspace{3pt}}&\parbox{\wcE}{\vspace{3pt}\noindent 230.07\vspace{3pt}}&\multirow{5}{*}{\parbox{\wcF}{\vspace{3pt}\noindent 1.06891\vspace{3pt}}}\\\cline{1-5} \parbox{\wcA}{\vspace{3pt}\noindent 522\vspace{3pt}}&\parbox{\wcB}{\vspace{3pt}\noindent PLRG1\vspace{3pt}}&\parbox{\wcC}{\vspace{3pt}\noindent pleiotropic regulator 1 (prl1homolog, arabidopsis); pleiotropic regulator 1 (prl1, arabidopsis homolog). [source:refseq;acc:nm\_002669]\vspace{3pt}}&\parbox{\wcD}{\vspace{3pt}\noindent 222.893\vspace{3pt}}&\parbox{\wcE}{\vspace{3pt}\noindent 208.523\vspace{3pt}}&\\\cline{1-5} \parbox{\wcA}{\vspace{3pt}\noindent 523\vspace{3pt}}&\parbox{\wcB}{\vspace{3pt}\noindent EXOSC2\vspace{3pt}}&\parbox{\wcC}{\vspace{3pt}\noindent exosome complex exonuclease rrp4 (ec 3.1.13.-) (ribosomal rna processing protein 4). [source:swissprot;acc:q13868]\vspace{3pt}}&\multirow{3}{*}{\parbox{\wcD}{\vspace{3pt}\noindent 215.237\vspace{3pt}}}&\multirow{3}{*}{\parbox{\wcE}{\vspace{3pt}\noindent 230.07\vspace{3pt}}}&\\\cline{1-3} \parbox{\wcA}{\vspace{3pt}\noindent 524\vspace{3pt}}&\parbox{\wcB}{\vspace{3pt}\noindent EXOSC3\vspace{3pt}}&\parbox{\wcC}{\vspace{3pt}\noindent exosome complex exonuclease rrp40 (ec 3.1.13.-) (ribosomal rna processing protein 40) (p10) (cgi-102). [source:swissprot;acc:q9nqt5]\vspace{3pt}}&&&\\\cline{1-3} \parbox{\wcA}{\vspace{3pt}\noindent 525\vspace{3pt}}&\parbox{\wcB}{\vspace{3pt}\noindent EXOSC5\vspace{3pt}}&\parbox{\wcC}{\vspace{3pt}\noindent exosome complex exonuclease rrp46 (ec 3.1.13.-) (ribosomal rna processing protein 46) (p12b) (chronic myelogenous leukemia tumor antigen 28). [source:swissprot;acc:q9nqt4]\vspace{3pt}}&&&\\\hline \parbox{\wcA}{\vspace{3pt}\noindent 526\vspace{3pt}}&\parbox{\wcB}{\vspace{3pt}\noindent RRP1\vspace{3pt}}&\parbox{\wcC}{\vspace{3pt}\noindent nnp-1 protein (novel nuclear protein 1) (nucleolar protein nop52) (nop52) (d21s2056e). [source:swissprot;acc:p56182]\vspace{3pt}}&\parbox{\wcD}{\vspace{3pt}\noindent 250.538\vspace{3pt}}&\parbox{\wcE}{\vspace{3pt}\noindent 234.401\vspace{3pt}}&\parbox{\wcF}{\vspace{3pt}\noindent 1.06884\vspace{3pt}}\\\hline \parbox{\wcA}{\vspace{3pt}\noindent 527\vspace{3pt}}&\parbox{\wcB}{\vspace{3pt}\noindent DDX31\vspace{3pt}}&\parbox{\wcC}{\vspace{3pt}\noindent dead (asp-glu-ala-asp) box polypeptide 31 isoform 1; dead/dexh helicase ddx31. [source:refseq;acc:nm\_022779]\vspace{3pt}}&\parbox{\wcD}{\vspace{3pt}\noindent 248.56\vspace{3pt}}&\parbox{\wcE}{\vspace{3pt}\noindent 232.579\vspace{3pt}}&\parbox{\wcF}{\vspace{3pt}\noindent 1.06871\vspace{3pt}}\\\hline \parbox{\wcA}{\vspace{3pt}\noindent 528\vspace{3pt}}&\parbox{\wcB}{\vspace{3pt}\noindent YME1L1\vspace{3pt}}&\parbox{\wcC}{\vspace{3pt}\noindent yme1-like 1 isoform 3; atp-dependent metalloprotease ftsh1 homolog. [source:refseq;acc:nm\_014263]\vspace{3pt}}&\parbox{\wcD}{\vspace{3pt}\noindent 222.146\vspace{3pt}}&\parbox{\wcE}{\vspace{3pt}\noindent 237.393\vspace{3pt}}&\parbox{\wcF}{\vspace{3pt}\noindent 1.06864\vspace{3pt}}\\\hline \parbox{\wcA}{\vspace{3pt}\noindent 529\vspace{3pt}}&\parbox{\wcB}{\vspace{3pt}\noindent DDX18\vspace{3pt}}&\parbox{\wcC}{\vspace{3pt}\noindent atp-dependent rna helicase ddx18 (dead-box protein 18) (myc-regulated dead-box protein) (mrdb). [source:swissprot;acc:q9nvp1]\vspace{3pt}}&\parbox{\wcD}{\vspace{3pt}\noindent 251.653\vspace{3pt}}&\parbox{\wcE}{\vspace{3pt}\noindent 235.506\vspace{3pt}}&\parbox{\wcF}{\vspace{3pt}\noindent 1.06856\vspace{3pt}}\\\hline \parbox{\wcA}{\vspace{3pt}\noindent 530\vspace{3pt}}&\parbox{\wcB}{\vspace{3pt}\noindent LSM6\vspace{3pt}}&\parbox{\wcC}{\vspace{3pt}\noindent u6 snrna-associated sm-like protein lsm6 (sm protein f). [source:swissprot;acc:q9y4y8]\vspace{3pt}}&\parbox{\wcD}{\vspace{3pt}\noindent 227.483\vspace{3pt}}&\parbox{\wcE}{\vspace{3pt}\noindent 212.994\vspace{3pt}}&\parbox{\wcF}{\vspace{3pt}\noindent 1.06803\vspace{3pt}}\\\hline \parbox{\wcA}{\vspace{3pt}\noindent 531\vspace{3pt}}&\parbox{\wcB}{\vspace{3pt}\noindent PRPF19\vspace{3pt}}&\parbox{\wcC}{\vspace{3pt}\noindent nuclear matrix protein nmp200 related to splicing factor prp19. [source:refseq;acc:nm\_014502]\vspace{3pt}}&\parbox{\wcD}{\vspace{3pt}\noindent 223.356\vspace{3pt}}&\parbox{\wcE}{\vspace{3pt}\noindent 209.149\vspace{3pt}}&\parbox{\wcF}{\vspace{3pt}\noindent 1.06793\vspace{3pt}}\\\hline \parbox{\wcA}{\vspace{3pt}\noindent 532\vspace{3pt}}&\parbox{\wcB}{\vspace{3pt}\noindent ZNF622\vspace{3pt}}&\parbox{\wcC}{\vspace{3pt}\noindent zinc finger-like protein 9. [source:refseq;acc:nm\_033414]\vspace{3pt}}&\multirow{3}{*}{\parbox{\wcD}{\vspace{3pt}\noindent 250.942\vspace{3pt}}}&\multirow{3}{*}{\parbox{\wcE}{\vspace{3pt}\noindent 235.004\vspace{3pt}}}&\multirow{3}{*}{\parbox{\wcF}{\vspace{3pt}\noindent 1.06782\vspace{3pt}}}\\\cline{1-3} \parbox{\wcA}{\vspace{3pt}\noindent 533\vspace{3pt}}&\parbox{\wcB}{\vspace{3pt}\noindent SLC45A2\vspace{3pt}}&\parbox{\wcC}{\vspace{3pt}\noindent membrane-associated transporter protein (aim-1 protein) (melanoma antigen aim1). [source:swissprot;acc:q9umx9]\vspace{3pt}}&&&\\\cline{1-3} \parbox{\wcA}{\vspace{3pt}\noindent 534\vspace{3pt}}&\parbox{\wcB}{\vspace{3pt}\noindent \vspace{3pt}}&\parbox{\wcC}{\vspace{3pt}\noindent guanine nucleotide-binding protein-like 1 (gtp-binding protein hsr1). [source:swissprot;acc:p36915]\vspace{3pt}}&&&\\\hline \parbox{\wcA}{\vspace{3pt}\noindent 535\vspace{3pt}}&\parbox{\wcB}{\vspace{3pt}\noindent POLR2H\vspace{3pt}}&\parbox{\wcC}{\vspace{3pt}\noindent dna-directed rna polymerases i, ii, and iii 17.1 kda polypeptide (ec 2.7.7.6) (rpb17) (rpb8) (rpabc3). [source:swissprot;acc:p52434]\vspace{3pt}}&\parbox{\wcD}{\vspace{3pt}\noindent 236.662\vspace{3pt}}&\parbox{\wcE}{\vspace{3pt}\noindent 252.708\vspace{3pt}}&\parbox{\wcF}{\vspace{3pt}\noindent 1.0678\vspace{3pt}}\\\hline \parbox{\wcA}{\vspace{3pt}\noindent 536\vspace{3pt}}&\parbox{\wcB}{\vspace{3pt}\noindent SSB\vspace{3pt}}&\parbox{\wcC}{\vspace{3pt}\noindent lupus la protein (sjogren syndrome type b antigen) (ss-b) (la ribonucleoprotein) (la autoantigen). [source:swissprot;acc:p05455]\vspace{3pt}}&\parbox{\wcD}{\vspace{3pt}\noindent 242.531\vspace{3pt}}&\parbox{\wcE}{\vspace{3pt}\noindent 227.136\vspace{3pt}}&\parbox{\wcF}{\vspace{3pt}\noindent 1.06778\vspace{3pt}}\\\hline \parbox{\wcA}{\vspace{3pt}\noindent 537\vspace{3pt}}&\parbox{\wcB}{\vspace{3pt}\noindent DHX15\vspace{3pt}}&\parbox{\wcC}{\vspace{3pt}\noindent putative pre-mrna splicing factor rna helicase (deah box protein 15) (atp-dependent rna helicase #46). [source:swissprot;acc:o43143]\vspace{3pt}}&\parbox{\wcD}{\vspace{3pt}\noindent 229.803\vspace{3pt}}&\parbox{\wcE}{\vspace{3pt}\noindent 215.301\vspace{3pt}}&\parbox{\wcF}{\vspace{3pt}\noindent 1.06736\vspace{3pt}}\\\hline \parbox{\wcA}{\vspace{3pt}\noindent 538\vspace{3pt}}&\parbox{\wcB}{\vspace{3pt}\noindent POLR2L\vspace{3pt}}&\parbox{\wcC}{\vspace{3pt}\noindent dna-directed rna polymerase ii 7.6 kda polypeptide (ec 2.7.7.6) (rpb10) (rpb7.6) (rpabc5). [source:swissprot;acc:p52436]\vspace{3pt}}&\parbox{\wcD}{\vspace{3pt}\noindent 237.627\vspace{3pt}}&\parbox{\wcE}{\vspace{3pt}\noindent 253.604\vspace{3pt}}&\parbox{\wcF}{\vspace{3pt}\noindent 1.06724\vspace{3pt}}\\\hline \parbox{\wcA}{\vspace{3pt}\noindent 539\vspace{3pt}}&\parbox{\wcB}{\vspace{3pt}\noindent MEMO1P\vspace{3pt}}&\parbox{\wcC}{\vspace{3pt}\noindent protein cgi-27 (c21orf19-like protein). [source:swissprot;acc:q9y316]\vspace{3pt}}&\parbox{\wcD}{\vspace{3pt}\noindent 236.964\vspace{3pt}}&\parbox{\wcE}{\vspace{3pt}\noindent 252.86\vspace{3pt}}&\parbox{\wcF}{\vspace{3pt}\noindent 1.06708\vspace{3pt}}\\\hline \parbox{\wcA}{\vspace{3pt}\noindent 540\vspace{3pt}}&\parbox{\wcB}{\vspace{3pt}\noindent SEPHS2\vspace{3pt}}&\parbox{\wcC}{\vspace{3pt}\noindent selenide,water dikinase 2 (ec 2.7.9.3) (selenophosphate synthetase 2) (selenium donor protein 2). [source:swissprot;acc:q99611]\vspace{3pt}}&\multirow{5}{*}{\parbox{\wcD}{\vspace{3pt}\noindent 222.156\vspace{3pt}}}&\multirow{5}{*}{\parbox{\wcE}{\vspace{3pt}\noindent 208.201\vspace{3pt}}}&\multirow{5}{*}{\parbox{\wcF}{\vspace{3pt}\noindent 1.06703\vspace{3pt}}}\\\cline{1-3} \parbox{\wcA}{\vspace{3pt}\noindent 541\vspace{3pt}}&\parbox{\wcB}{\vspace{3pt}\noindent MICAL2\vspace{3pt}}&\parbox{\wcC}{\vspace{3pt}\noindent flavoprotein oxidoreductase mical2. [source:refseq;acc:nm\_014632]\vspace{3pt}}&&&\\\cline{1-3} \parbox{\wcA}{\vspace{3pt}\noindent 542\vspace{3pt}}&\parbox{\wcB}{\vspace{3pt}\noindent INPP4B\vspace{3pt}}&\parbox{\wcC}{\vspace{3pt}\noindent inositol polyphosphate-4-phosphatase, type ii, 105kd; inositol polyphosphate 4-phosphatase ii; 4-phosphatase ii. [source:refseq;acc:nm\_003866]\vspace{3pt}}&&&\\\cline{1-3} \parbox{\wcA}{\vspace{3pt}\noindent 543\vspace{3pt}}&\parbox{\wcB}{\vspace{3pt}\noindent SEPHS1\vspace{3pt}}&\parbox{\wcC}{\vspace{3pt}\noindent selenide,water dikinase 1 (ec 2.7.9.3) (selenophosphate synthetase 1) (selenium donor protein 1). [source:swissprot;acc:p49903]\vspace{3pt}}&&&\\\cline{1-3} \parbox{\wcA}{\vspace{3pt}\noindent 544\vspace{3pt}}&\parbox{\wcB}{\vspace{3pt}\noindent INPP4A\vspace{3pt}}&\parbox{\wcC}{\vspace{3pt}\noindent inositol polyphosphate-4-phosphatase, type 1 isoform b; inositol polyphosphate-4-phosphatase, type i, 107kd; 4-phosphatase i; inositol polyphosphate-4-phosphatase i. [source:refseq;acc:nm\_001566]\vspace{3pt}}&&&\\\hline \parbox{\wcA}{\vspace{3pt}\noindent 545\vspace{3pt}}&\parbox{\wcB}{\vspace{3pt}\noindent EIF6\vspace{3pt}}&\parbox{\wcC}{\vspace{3pt}\noindent eukaryotic translation initiation factor 6 (eif-6) (b4 integrin interactor) (cab) (p27(bbp)) (b(2)gcn homolog). [source:swissprot;acc:p56537]\vspace{3pt}}&\parbox{\wcD}{\vspace{3pt}\noindent 248.866\vspace{3pt}}&\parbox{\wcE}{\vspace{3pt}\noindent 233.287\vspace{3pt}}&\parbox{\wcF}{\vspace{3pt}\noindent 1.06678\vspace{3pt}}\\\hline \parbox{\wcA}{\vspace{3pt}\noindent 546\vspace{3pt}}&\parbox{\wcB}{\vspace{3pt}\noindent WAS\vspace{3pt}}&\parbox{\wcC}{\vspace{3pt}\noindent wiskott-aldrich syndrome protein (wasp). [source:swissprot;acc:p42768]\vspace{3pt}}&\parbox{\wcD}{\vspace{3pt}\noindent 207.222\vspace{3pt}}&\parbox{\wcE}{\vspace{3pt}\noindent 194.262\vspace{3pt}}&\parbox{\wcF}{\vspace{3pt}\noindent 1.06671\vspace{3pt}}\\\hline \parbox{\wcA}{\vspace{3pt}\noindent 547\vspace{3pt}}&\parbox{\wcB}{\vspace{3pt}\noindent CRK\vspace{3pt}}&\parbox{\wcC}{\vspace{3pt}\noindent proto-oncogene c-crk (p38) (adapter molecule crk). [source:swissprot;acc:p46108]\vspace{3pt}}&\multirow{3}{*}{\parbox{\wcD}{\vspace{3pt}\noindent 207.26\vspace{3pt}}}&\multirow{3}{*}{\parbox{\wcE}{\vspace{3pt}\noindent 194.346\vspace{3pt}}}&\multirow{3}{*}{\parbox{\wcF}{\vspace{3pt}\noindent 1.06645\vspace{3pt}}}\\\cline{1-3} \parbox{\wcA}{\vspace{3pt}\noindent 548\vspace{3pt}}&\parbox{\wcB}{\vspace{3pt}\noindent ABL2\vspace{3pt}}&\parbox{\wcC}{\vspace{3pt}\noindent tyrosine-protein kinase abl2 (ec 2.7.1.112) (tyrosine kinase arg). [source:swissprot;acc:p42684]\vspace{3pt}}&&&\\\cline{1-3} \parbox{\wcA}{\vspace{3pt}\noindent 549\vspace{3pt}}&\parbox{\wcB}{\vspace{3pt}\noindent \vspace{3pt}}&\parbox{\wcC}{\vspace{3pt}\noindent proto-oncogene tyrosine-protein kinase src (ec 2.7.1.112) (p60-src) (c-src). [source:swissprot;acc:p12931]\vspace{3pt}}&&&\\\hline nd{longtable}
    Legend:
    - Rank is the rank after comparing the two networks
    - Gene is the ensembl human gene identifier measured by 1 or more probes on the microarray
    - Hugo is the HGNC identifier if it exists
    - Value Type describes how the microarray measurement was processed. Ranked indicates that we sorted all measurements and use the rank as red and green value. Measured is the normal measurement. Squared and Rooted are the square and square root respecitcely. This might be valueable to compensate for non linear light distributions.
    - Network Comparison Type describes whether we divided the red and green types or whether we sutractcted them
    - Interaction Map specifies whether we used only the hig hconfidence protein-protein interactions or also included the low confidence interactions.
    - Filtered specifies whether we only included the high confidence microarry measurements or not.

    - http://analysis.yellowcouch.org/